Your Weekly Dose of News in Pharma, Biotech and Health
From the challenge of tackling the 'silent pandemic' of superbugs, to Pharma navigating through an 'age of uncertainty' with hurdles like regulatory challenges, patent cliffs, and Medicare's drug pricing negotiations. Insights on the Innovative Medicines Fund critique, orphan drugs' unique dynamics, and the breakthrough potential of Y chromosome sequencing captivate the field. Don't miss out on the latest developments in the fight against cancer, with President Biden's $24M investment in mRNA tech and the proposal for a paediatric cancer fund. And in the marketing arena, Moderna's inspirational 'Change Makers' campaign featuring tennis legend Arthur Ashe and Sanofi's impactful meningitis awareness initiative showcase the power of storytelling and purpose-driven initiatives.
Image source: Endpoints News
Health
Superbugs: why it’s so hard to stop the ‘silent pandemic’
Marketing
Moderna highlights tennis legend Arthur Ashe in second ‘Change Makers’ campaign at US Open, ahead of fall vaccine season
Sanofi flies new flag for meningitis awareness, marking one year to the Paris Paralympics with three Team Sanofi athletes
Pharma
Pharma enters ‘age of uncertainty’ amid challenges from IRA, FTC and patent cliffs
Winners and losers from Medicare’s list of drugs subject to price negotiation
ABPI, researchers criticize NHS’ Innovative Medicines Fund, with no new therapies available over a year after formation
Orphan drugs: small markets, large rewards
Research
Biden awards $24M to develop mRNA tech targeting cancer, other diseases
The first complete sequence of Y chromosome offers chance to solve longstanding genetic mysteries
Non-profit and industry investors propose paediatric cancer fund
For an overview of previous Weekly Notables, visit our Archive